Discussion
Evrysdi (risdiplam) may improve nighttime breathing in adults with spinal muscular atrophy (SMA), a small, real-world study in Italy found. After 12 months on Evrysdi, study participants experienced fewer episodes of breathing that stopped or became too shallow during sleep, along with fewer associated drops in blood oxygen…